← Back to Clinical Trials
Recruiting NCT06815952

NCT06815952 Enhancing Difficult Laryngoscopy Prediction Through A Mixed Scoring System

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06815952
Status Recruiting
Phase
Sponsor American University of Beirut Medical Center
Condition Intubation
Study Type OBSERVATIONAL
Enrollment 1,100 participants
Start Date 2025-02-20
Primary Completion 2026-02-01

Trial Parameters

Condition Intubation
Sponsor American University of Beirut Medical Center
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,100
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-02-20
Completion 2026-02-01

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study aims to develop a comprehensive airway assessment score including traditional bedside clinical tests and ultrasound measurements with high accuracy in predicting difficult airway, and to validate it through testing it on a large population sample. The main question it aims to answer is: Is the comprehensive scoring system that includes clinical bedside and ultrasound measurements developed to predict difficult airways valid in a large population sample? Adult patients undergoing general anesthesia with American Society of Anesthesiologists (ASA) classification 1-4 will be recruited. Traditional and ultrasound measurements will be collected.

Eligibility Criteria

Inclusion Criteria: * Adult patients undergoing general anesthesia * American Society of Anesthesiologists (ASA) classification 1-4 * Emergency or elective cases Exclusion Criteria: * Patients with confirmed history of difficult airway * Patients with maxillofacial trauma or cervical spine injury or instability * Pregnant patients * Patients with a history of head and neck cancer * Patients with known subglottic stenosis * Patients requiring a double lumen tube insertion * Patients with a history of neck radiotherapy

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology